<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To study the clinicopathologic features, immunohistochemical findings, EBV and c-myc gene status of intra-abdominal non-Hodgkin B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> occurring in children </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Seventy-four cases of pediatric intra-abdominal non-Hodgkin B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> were retrieved from the archival file </plain></SENT>
<SENT sid="2" pm="."><plain>The cases were classified according to the 2008 WHO classification </plain></SENT>
<SENT sid="3" pm="."><plain>Tissue microarray including <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissues from <z:hpo ids='HP_0000001'>all</z:hpo> the 74 cases was produced </plain></SENT>
<SENT sid="4" pm="."><plain>Immunohistochemical study (SP method) for CD20, CD3, CD79a, CD10, bcl-6, MUM1, bcl-2, CD43, CD38 and Ki-67 was performed </plain></SENT>
<SENT sid="5" pm="."><plain>In-situ hybridization for Epstein-Barr virus-encoded <z:chebi fb="40" ids="33697">RNA</z:chebi> (EBER) and fluorescence in-situ hybridization for c-myc gene were also carried out </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Amongst the 74 cases studied, 65 of them (87.8%) were Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>), 4 cases (5.4%) were diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>) and the remaining 5 cases (6.8%) showed features in-between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) </plain></SENT>
<SENT sid="7" pm="."><plain>The patients often presented with <z:hpo ids='HP_0002027'>abdominal pain</z:hpo>, abdominal masses, <z:hpo ids='HP_0002595'>ileus</z:hpo> and <z:hpo ids='HP_0002576'>intussusception</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>The ileocecal bowel wall and mesenteric lymph nodes were commonly involved </plain></SENT>
<SENT sid="9" pm="."><plain>The <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells were of high histologic grade and suggested an aggressive clinical behavior </plain></SENT>
<SENT sid="10" pm="."><plain>The staining for CD20 and CD79a were positive in <z:hpo ids='HP_0000001'>all</z:hpo> of the cases, while CD3 was negative </plain></SENT>
<SENT sid="11" pm="."><plain>The positive rates of CD10, bcl-6, bcl-2, MUM1, CD43, CD38 and EBER in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> were 96.9% (63 cases), 95.4% (62 cases), 0 (0 case), 23.1% (15 cases), 70.8% (46 cases), 96.9% (63 cases) and 41.5% (27 cases), respectively </plain></SENT>
<SENT sid="12" pm="."><plain>Fifty-four cases carried translocation of c-myc gene </plain></SENT>
<SENT sid="13" pm="."><plain>As for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>, the positive cases of CD10, bcl-6, bcl-2, MUM1, CD43, CD38 and EBER were 3 cases, 2 cases, 3 cases, 2 cases, 2 cases, 2 cases and 0 case, respectively </plain></SENT>
<SENT sid="14" pm="."><plain>One of these cases showed c-myc gene translocation </plain></SENT>
<SENT sid="15" pm="."><plain>Amongst the 4 cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>, 2 of them belonged to germinal center B-cell-like subtype, while the remaining 2 cases were of non-germinal center B-cell-like subtype </plain></SENT>
<SENT sid="16" pm="."><plain>The expression rates of CD10, bcl-6, bcl-2, MUM1, CD43, CD38 and EBER in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> were 5/5, 4/5, 0, 3/5, 5/5, 3/5 and 0, respectively </plain></SENT>
<SENT sid="17" pm="."><plain>Three of the cases were positive for c-myc gene translocation </plain></SENT>
<SENT sid="18" pm="."><plain>CONCLUSIONS: The majority of pediatric intra-abdominal non-Hodgkin B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> belonged to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> </plain></SENT>
<SENT sid="19" pm="."><plain>They have characteristic clinical presentation and sites of predilection and are often associated with an aggressive clinical behavior </plain></SENT>
<SENT sid="20" pm="."><plain>Thorough morphologic assessment, immunohistochemistry and in-situ hybridization play an important role in subtyping this group of lymphoid <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> </plain></SENT>
</text></document>